Imanol Arozarena

3.5k total citations
36 papers, 2.2k citations indexed

About

Imanol Arozarena is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Imanol Arozarena has authored 36 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Cell Biology. Recurrent topics in Imanol Arozarena's work include Melanoma and MAPK Pathways (15 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and Cutaneous Melanoma Detection and Management (7 papers). Imanol Arozarena is often cited by papers focused on Melanoma and MAPK Pathways (15 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and Cutaneous Melanoma Detection and Management (7 papers). Imanol Arozarena collaborates with scholars based in Spain, United Kingdom and United States. Imanol Arozarena's co-authors include Claudia Wellbrock, Piero Crespo, Richard Marais, David Matallanas, Marı́a T. Berciano, Fernando Calvo, Victoria Sanz‐Moreno, Robert Hayward, Michael P. Smith and Miguel Lafarga and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Imanol Arozarena

36 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Imanol Arozarena Spain	24	1.6k	843	484	468	257	36	2.2k
Jessie Villanueva United States	18	1.6k 1.0×	799 0.9×	314 0.6×	282 0.6×	361 1.4×	30	2.1k
Robert Hayward United Kingdom	16	1.7k 1.1×	812 1.0×	316 0.7×	274 0.6×	214 0.8×	21	2.1k
Alastair J. King United States	18	1.6k 1.0×	659 0.8×	289 0.6×	223 0.5×	149 0.6×	28	2.0k
Maria Karasarides United States	12	1.8k 1.1×	833 1.0×	307 0.6×	260 0.6×	253 1.0×	20	2.3k
Scott T. Eblen United States	24	1.8k 1.1×	445 0.5×	552 1.1×	148 0.3×	218 0.8×	41	2.3k
Amaya Virós United Kingdom	21	2.1k 1.3×	1.6k 1.9×	625 1.3×	459 1.0×	496 1.9×	46	3.3k
Jeffrey D. Bjorge Canada	20	1.5k 0.9×	493 0.6×	278 0.6×	328 0.7×	197 0.8×	32	1.9k
Robert L. Kortum United States	25	1.2k 0.7×	365 0.4×	209 0.4×	343 0.7×	160 0.6×	40	1.6k
Azucena Esparís‐Ogando Spain	27	1.3k 0.8×	861 1.0×	198 0.4×	171 0.4×	262 1.0×	45	2.0k
Juan Carlos Montero Spain	31	1.7k 1.1×	1.1k 1.3×	246 0.5×	229 0.5×	376 1.5×	90	2.8k

Countries citing papers authored by Imanol Arozarena

Since Specialization

Citations

This map shows the geographic impact of Imanol Arozarena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imanol Arozarena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imanol Arozarena more than expected).

Fields of papers citing papers by Imanol Arozarena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imanol Arozarena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imanol Arozarena. The network helps show where Imanol Arozarena may publish in the future.

Co-authorship network of co-authors of Imanol Arozarena

This figure shows the co-authorship network connecting the top 25 collaborators of Imanol Arozarena. A scholar is included among the top collaborators of Imanol Arozarena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imanol Arozarena. Imanol Arozarena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aldaz, Paula, Irene Otero, Karina Ausín, et al.. (2024). Drug-Induced Reorganisation of Lipid Metabolism Limits the Therapeutic Efficacy of Ponatinib in Glioma Stem Cells. Pharmaceutics. 16(6). 728–728. 2 indexed citations

Arozarena, Imanol, Diego Serrano, Esther Redín, et al.. (2023). Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer. Cancers. 15(12). 3076–3076. 11 indexed citations

Otero, Irene, Haritz Moreno, Paula Aldaz, et al.. (2022). The Regulators of Peroxisomal Acyl-Carnitine Shuttle CROT and CRAT Promote Metastasis in Melanoma. Journal of Investigative Dermatology. 143(2). 305–316.e5. 17 indexed citations

Fernández‐Irigoyen, Joaquín, Enrique Santamaría, Imanol Arozarena, et al.. (2021). Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the Cervix. Cancers. 13(7). 1739–1739. 4 indexed citations

Aldaz, Paula, Amaya Fernández‐Celis, Natalia López‐Andrés, & Imanol Arozarena. (2021). Novel Insights into the Role of the Mineralocorticoid Receptor in Human Glioblastoma. International Journal of Molecular Sciences. 22(21). 11656–11656. 5 indexed citations

Arozarena, Imanol, et al.. (2020). Study of cutaneous melanoma recurrences after sentinel node biopsy: Patterns of dissemination and use of complementary test in follow‐up. European Journal of Cancer Care. 30(1). e13344–e13344. 1 indexed citations

Gato, María, Miren Zuazo, Hugo Arasanz, et al.. (2017). PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity. Cell Reports. 20(8). 1818–1829. 223 indexed citations

Arozarena, Imanol & Claudia Wellbrock. (2017). Overcoming resistance to BRAF inhibitors. Annals of Translational Medicine. 5(19). 387–387. 94 indexed citations

Erice, Oihane, Michael P. Smith, Ibai Goicoechea, et al.. (2015). MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide. Molecular Cancer Therapeutics. 14(5). 1236–1246. 33 indexed citations

10.

Wellbrock, Claudia & Imanol Arozarena. (2015). Microphthalmia‐associated transcription factor in melanoma development and MAP‐kinase pathway targeted therapy. Pigment Cell & Melanoma Research. 28(4). 390–406. 151 indexed citations

11.

Smith, Michael P., Jennifer Ferguson, Imanol Arozarena, et al.. (2012). Effect of SMURF2 Targeting on Susceptibility to MEK Inhibitors in Melanoma. JNCI Journal of the National Cancer Institute. 105(1). 33–46. 82 indexed citations

12.

Arozarena, Imanol, Berta Sanchez‐Laorden, Leisl Packer, et al.. (2011). Oncogenic BRAF Induces Melanoma Cell Invasion by Downregulating the cGMP-Specific Phosphodiesterase PDE5A. Cancer Cell. 19(1). 45–57. 168 indexed citations

13.

Casar, Berta, Imanol Arozarena, Victoria Sanz‐Moreno, et al.. (2008). Ras Subcellular Localization Defines Extracellular Signal-Regulated Kinase 1 and 2 Substrate Specificity through Distinct Utilization of Scaffold Proteins. Molecular and Cellular Biology. 29(5). 1338–1353. 98 indexed citations

14.

Wellbrock, Claudia, Imanol Arozarena, Shawn M. Davidson, et al.. (2006). FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKC epsilon, B-Raf and S6K2. University of Huddersfield Repository (University of Huddersfield). 9 indexed citations

15.

Pardo, Olivier E., Claudia Wellbrock, Muriel Aubert, et al.. (2006). FGF‐2 protects small cell lung cancer cells from apoptosis through a complex involving PKCε, B‐Raf and S6K2. The EMBO Journal. 25(13). 3078–3088. 144 indexed citations

16.

Matallanas, David, Victoria Sanz‐Moreno, Imanol Arozarena, et al.. (2005). Distinct Utilization of Effectors and Biological Outcomes Resulting from Site-Specific Ras Activation: Ras Functions in Lipid Rafts and Golgi Complex Are Dispensable for Proliferation and Transformation. Molecular and Cellular Biology. 26(1). 100–116. 107 indexed citations

17.

Arozarena, Imanol, David Matallanas, Marı́a T. Berciano, et al.. (2004). Activation of H-Ras in the Endoplasmic Reticulum by the RasGRF Family Guanine Nucleotide Exchange Factors. Molecular and Cellular Biology. 24(4). 1516–1530. 83 indexed citations

18.

Matallanas, David, Imanol Arozarena, Marı́a T. Berciano, et al.. (2003). Differences on the Inhibitory Specificities of H-Ras, K-Ras, and N-Ras (N17) Dominant Negative Mutants Are Related to Their Membrane Microlocalization. Journal of Biological Chemistry. 278(7). 4572–4581. 100 indexed citations

19.

Delgado, M. Dolores, José P. Vaqué, Imanol Arozarena, et al.. (2000). H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism. Oncogene. 19(6). 783–790. 51 indexed citations

20.

Arozarena, Imanol, et al.. (2000). Distinct carboxy‐termini confer divergent characteristics to the mitogen‐activated protein kinase p38α and its splice isoform Mxi2. FEBS Letters. 474(2-3). 169–174. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact